Natalia Shpiro
Papers
1
Total Citations
310
H-Index
1
About
Natalia Shpiro is a distinguished chemical biologist whose research centers on kinase inhibitor design and the molecular mechanisms of stress-activated protein kinases. Her most impactful work includes the landmark 2005 study on BIRB796, a compound that inhibits all p38 MAPK isoforms in vitro and in vivo, which has garnered over 310 citations. This research demonstrated that BIRB796, already in clinical trials for inflammatory diseases, also inhibits SAPK3/p38γ at higher concentrations, revealing broader therapeutic potential. Shpiro’s contributions have significantly advanced understanding of kinase selectivity and drug development, particularly for targeting inflammatory and stress-response pathways. Her work is widely recognized for its translational impact, bridging basic kinase biology with clinical applications. With a citation count reflecting her influence, Shpiro continues to shape the field of chemical biology, inspiring researchers exploring targeted therapies for complex diseases.
Research Focus
Key Achievements
Top Papers
- 1BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo310 citations · 2005